Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2024Cardiovascular ResearchOpen Access

Zonation and ligand and dose dependence of sphingosine 1-phosphate receptor-1 signalling in blood and lymphatic vasculature

View Full Paper
Ask AI
Bookmark
Share

Authors

IGIlaria Del GaudioInsermANAnja NitzscheInsermKBKevin BoyéInserm

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gaudio et al. (2024) studied this question.

synapsesocial.com/papers/68e5dc63b6db6435875724f7https://doi.org/10.1093/cvr/cvae168
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P <sub>1</sub> ) modulation2010 · 581 citations
  2. 2Finding a Way Out: S1P Signaling and Immune Cell Migration2020 · 126 citations
  3. 3Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate2007 · 886 citations
  4. 4Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications2014 · 211 citations
  5. 5Endothelial S1pr1 regulates pressure overload‐induced cardiac remodelling through AKT‐eNOS pathway2019 · 40 citations